will semaglutide get cheaper Popular — and expensive — GLP-1 weight loss drugs just got a lot for many older Americans Popular — and expensive —

Out of a population of 150 LifeMD patients, on average, patients on Triple Therapy lost 7 pounds within the first three months of treatment.

A higher research reference point

Seven additional phase 3 trials are expected to complete in 2026

Policy changes like the Inflation Reduction Acts $2,000 out-of-pocket (OOP) cap for Medicare Part D beneficiaries may offer some relief, as patients who reach the cap pay $0 thereafter, but they also risk prompting payers to tighten coverage for high-cost drugs, especially those indicated for obesity

If cardiovascular health is what you think is important for deciding between these drug classes, I think our most recent study provides some strong evidence

Everyone is allowed to have their own opinion